Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

66. Shaddix B P, Miller J L, Johnson P N. Letter to the editor rebuttal: Which PGY1 pharmacy residency is right for me? Advantages and disadvantages of pediatric-focused and traditional PGY1 pharmacy programs. Journal of Pediatric Pharmacology and Therapeutics. 2020; 25 : 531-533

67. Nguyen T T, Bergeron E, Lewis T V, Miller J L, Hagemann T M, Neely S, Johnson P N. Descriptive study of discharge medications in pediatric patients. SAGE open medicine. 2020; 8 : 2050312120927945

68. Medina M, Tran A L, Bhakta K, Klatt R A, Miller J L. Tips for writing pharmacy residency letters of intent. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020; 77 : 605-607

69. Capino A C, Thomas A N, Baylor S, Hughes K M, Miller J L, Johnson P N. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2020; 25 : 81-95

70. Shaddix B P, Harkin M, Miller J L, Johnson P N. Which PGY1 Pharmacy Residency Is Right for Me? Advantages and Disadvantages of Pediatric-Focused and Traditional PGY1 Pharmacy Programs. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2020; 25 : 273-277

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

6. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.


7. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.


10. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More